US drug approvals
162 approvals with a product on the US market
- Methylprednisolone Acetate ANDA219662 · approved 2 Nov 2026
- Epinephrine ANDA220400 · approved 26 Oct 2026
- Buprenorphine Hydrochloride ANDA221145 · approved 15 Oct 2026
- Levocarnitine ANDA220181 · approved 30 Sep 2026
- Atropine Sulfate ANDA219996 · approved 31 Jul 2026
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.